Long-Term 3-Year Efficacy of Dupilumab in QUEST Patients Enrolled in LIBERTY ASTHMA TRAVERSE

被引：0
|
作者：
Papi, A. [1 ]
Bourdin, A. [2 ]
Watz, H. [3 ]
Pavord, I. D. [4 ]
Domingo, C. [5 ]
Wechsler, M. E. [6 ]
Mao, X. [7 ]
Ortiz, B. [8 ]
Djandji, M. [9 ]
Mannent, L. P. [10 ]
Ruddy, M. [8 ]
Laws, E. [7 ]
Amin, N. [8 ]
Lederer, D. J. [8 ]
Hardin, M. [9 ]
机构：
[1] Univ Ferrara, S Anna Univ Hosp, Resp Med Unit, Ferrara, Italy
[2] Montpellier Univ Hosp, Montpellier, France
[3] German Ctr Lung Res DZL, Airway Res Ctr North ARCN, LungenClin Grosshansdorf, Pulm Res Inst, Grosshansdorf, Germany
[4] Univ Oxford, NIHR Oxford Biomed Res Ctr, Oxford, England
[5] Autonomous Univ Barcelona, Sabadell, Corp Sanitaria Parc Tauli, Barcelona, Spain
[6] Natl Jewish Hlth, Denver, CO USA
[7] Sanofi, Bridgewater, NJ USA
[8] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[9] Sanofi, Cambridge, MA USA
[10] Sanofi, Chilly Mazarin, France
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1460
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study
    Tohda, Yuji
    Nakamura, Yoichi
    Fujisawa, Takao
    Ebisawa, Motohiro
    Msihid, Jerome
    Djandji, Michel
    Ortiz, Benjamin
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    Ishida, Masato
    Arima, Kazuhiko
    ALLERGOLOGY INTERNATIONAL, 2023, 72 (01) : 89 - 99
  • [42] Dupilumab Efficacy in LIBERTY ASTHMA QUEST Patients With Uncontrolled, Moderate-to-Severe Asthma By Allergen Sensitization Status
    Corren, Jonathan
    Jackson, David
    Casale, Thomas
    Borish, Larry
    Rabe, Klaus
    Busse, William
    Maspero, Jorge
    Jackson, Daniel
    Daizadeh, Nadia
    Ortiz, Benjamin
    Jacob-Nara, Juby
    Khodzhayev, Angela
    Rowe, Paul
    Djandji, Michel
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB15 - AB15
  • [43] Dupilumab efficacy in asthma patients with comorbid chronic rhinosinusitis or nasal polyposis (CRS/NP) in LIBERTY ASTHMA QUEST
    Pavord, Ian Douglas
    Ford, Linda
    Sher, Lawrence
    Rabe, Klaus F.
    Park, Hae-Sim
    Cosio, Borja G.
    Foster, Meredith C.
    Staudinger, Heribert
    Maroni, Jaman
    Rowe, Paul
    Amin, Nikhil
    Pirozzi, Gianluca
    Ruddy, Marcella
    Akinlade, Bolanale
    Graham, Neil M. H.
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [44] DUPILUMAB EFFICACY IN UNCONTROLLED, MODERATE-TO-SEVERE ALLERGIC ASTHMA IN THE PHASE 3 LIBERTY ASTHMA QUEST STUDY
    Castro, M.
    Corren, J.
    Hanania, N.
    Pavord, I.
    Quirce, S.
    Thangavelu, K.
    Rice, M.
    O'Riordan, T.
    Maroni, J.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Graham, N.
    Teper, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S8 - S8
  • [45] Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION) : an open-label extension study
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Katelaris, Constance H.
    Fiocchi, Alessandro G.
    Gagnon, Remi
    de Mir, Ines
    Guilbert, Theresa W.
    Jackson, Daniel J.
    Staudinger, Heribert W.
    Laws, Elizabeth
    Mannent, Leda P.
    Akinlade, Bolanle
    Maloney, Jennifer
    Tawo, Kelsey
    Khokhar, Faisal A.
    Li, Ning
    Hardin, Megan
    Abdulai, Raolat M.
    Lederer, David J.
    Robinson, Lacey B.
    LANCET RESPIRATORY MEDICINE, 2024, 12 (01): : 45 - 54
  • [46] Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study
    Maspero, Jorge F.
    Cardona, Guido
    Schonffeldt, Patricia
    Tolcachier, Alberto
    Gonzalez-Diaz, Sandra N.
    Yanez, Anahi
    Galvao, Clovis E.
    Msihid, Jerome
    Gall, Rebecca
    Siddiqui, Shahid
    Rowe, Paul J.
    Deniz, Yamo
    Jacob-Nara, Juby A.
    Djandji, Michel
    JOURNAL OF ASTHMA, 2023, 60 (05) : 981 - 990
  • [47] Long-term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3-year real-life study
    Chiei-Gallo, Alessandra
    Barei, Francesca
    Calzari, Paolo
    Pisapia, Armando
    Marzano, Angelo V.
    Ferrucci, Silvia M.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024,
  • [48] Multicenter Study on the Long-Term (3-Year) Efficacy of Lanthanum Carbonate in Dialysis Patients
    Ando, Ryoichi
    Yama, Satomi
    Ohnishi, Tsuyoshi
    Iwamoto, Shunsuke
    Kimura, Hitoshi
    Chida, Yoshiko
    Ishida, Yuji
    Yamada, Kouei
    Inagaki, Yuichiro
    Takayama, Masanobu
    Tachibana, Ken
    Kikuchi, Kan
    Inoue, Atsushi
    Ohtsuka, Masakazu
    THERAPEUTIC APHERESIS AND DIALYSIS, 2014, 18 : 2 - 8
  • [49] Long-term dupilumab efficacy in asthma patients with/without chronic rhinosinusitis/nasal polyposis
    Menzies-Gow, A.
    Peters, A.
    Kuna, P.
    Rabe, K.
    Altincatal, A.
    Deniz, Y.
    Jacob-Nara, J.
    Nash, S.
    Ortiz, B.
    Djandji, M.
    Rowe, P.
    RESPIROLOGY, 2022, 27 : 103 - 103
  • [50] Dupilumab efficacy is not affected by prior asthma exacerbation status in LIBERTY ASTHMA TRAVERSE open-label extension study
    Papi, A.
    Castro, M.
    Busse, W. W.
    Langton, D.
    Korn, S.
    Xia, C.
    Soler, X.
    Pandit-Abid, N.
    Amr, R.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    THORAX, 2023, 78 (SUPPL_4) : A85 - A85
12345